About this role
Veeva is building the industry cloud for Life Sciences through software, data, AI, and business consulting working together. Learn more about our products, vision, values, and status as a Public Benefit Corporation (PBC) on our website. Consulting is changing, and we’re not like other firms. Launched in 2019, Veeva Business Consulting has grown quickly and organically to over 500 global experts who combine deep domain knowledge with innovative technology to help Life Sciences companies work in a more efficient and connected way. We are growing aggressively as we look towards 2030. We are seeking great people to help shape the future of the industry with the world’s leading software, data, AI, and expertise at their back. The Role We are hiring high potential people who are early in their careers and want to pivot into Life Sciences Consulting through our Master Class Program. Breaking into business consulting after starting your career down a different path can be hard. As an alternative to an MBA, this program is intentionally designed as the entry path to shape experienced professionals as Business Consultants capable of making an impact for the Life Sciences industry. Early in the program, you will own key workstreams on customer-facing engagements to create high-impact business solutions while collaborating with team members at all levels of Veeva. You will be given the tools and resources to accelerate your consulting skills development. Our Business Consulting team builds effective business and operational improvement strategies powered by Veeva’s unique industry insights, and market-leading technology. Our offerings are focused on speeding drug development, launching treatments more effectively, and shaping the best engagement for our customers. If you’re graduating with an advanced degree, have 3-5 years of industry experience, or have served your country and are excited to pivot your career into consulting for a critical industry, Master Class is for you. The anticipated start date is April 2027.